The best healthcare stocks right now, ranked.
Of the 195 investable healthcare stocks we score, these 25 rank highest on Ticker Nerd's factor model today — all nine factor families at once, not one metric. Every stock in P123's Healthcare sector, the taxonomy the rank is built on.
Every score is a percentile across the whole US universe we cover — a 92 beats 92% of it. How the model was built and blind-tested is on the methodology page; what each factor means is on the factor glossary.
| Ticker | Company | Mkt cap | Rank | 1w rank Δ | Revisions | Value | Momentum | Quality | Accruals | Issuance | Growth | Volatility | Size |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. Biotechnology | $16.8B | 99.7 | 0.0 | 85.2 | 99.4 | 93.4 | 98.1 | 82.4 | 94.9 | 74.2 | 98.7 | 10.9 | |
Xeris Biopharma Holdings, Inc. Drug Manufacturers - Specialty & Generic | $2.4B | 99.6 | +13.6 | 86.9 | 96.9 | 92.9 | 98.6 | 86.2 | 71.8 | 65.8 | 93.3 | 32.2 | |
Progyny, Inc. Healthcare Plans | $2.7B | 99.6 | +1.2 | 77.5 | 78.8 | 91.8 | 96.5 | 88.5 | 93.8 | 76.3 | 83.6 | 30.9 | |
Pediatrix Medical Group, Inc. Medical Care Facilities | $2.6B | 99.4 | −0.3 | 91.3 | 96.0 | 98.1 | 89.1 | 71.8 | 96.2 | 43.2 | 81.6 | 31.1 | |
Haemonetics Corp. Medical Devices | $5.6B | 98.5 | −0.6 | 73.7 | 81.8 | 97.9 | 86.5 | 91.7 | 97.8 | 50.1 | 89.5 | 21.0 | |
FIGS, Inc. Apparel Manufacturing | $3.4B | 98.1 | 0.0 | 94.5 | 75.0 | 98.1 | 93.3 | 73.3 | 46.5 | 90.2 | 57.9 | 27.9 | |
Cardinal Health, Inc. Medical Distribution | $62.0B | 97.8 | +3.3 | 75.6 | 89.3 | 96.6 | 87.1 | 74.2 | 88.5 | 68.1 | 98.6 | 4.2 | |
Halozyme Therapeutics, Inc. Biotechnology | $14.0B | 97.8 | −0.4 | 89.0 | 98.6 | 96.1 | 98.7 | 67.6 | 45.7 | 68.7 | 97.5 | 12.3 | |
Aurinia Pharmaceuticals, Inc. Biotechnology | $2.2B | 97.8 | +0.2 | 77.8 | 99.3 | 83.8 | 96.8 | 22.1 | 87.6 | 82.0 | 96.1 | 33.4 | |
Royalty Pharma Plc Biotechnology | $38.9B | 97.6 | +11.4 | 88.6 | 85.1 | 99.4 | 73.0 | 74.0 | 77.8 | 70.3 | 99.4 | 5.9 | |
DexCom, Inc. Medical Devices | $32.6B | 97.5 | −0.4 | 73.0 | 90.8 | 82.9 | 94.3 | 64.3 | 99.0 | 79.9 | 80.2 | 6.7 | |
Protagonist Therapeutics, Inc. Biotechnology | $8.6B | 97.3 | −0.3 | 81.3 | 93.9 | 94.7 | 83.3 | 68.9 | 54.7 | 82.8 | 98.1 | 16.2 | |
Kiniksa Pharmaceuticals International Plc Drug Manufacturers - Specialty & Generic | $6.8B | 97.3 | +0.5 | 74.9 | 96.2 | 99.2 | 91.3 | 62.2 | 54.0 | 84.0 | 94.7 | 18.7 | |
Lifestance Health Group, Inc. Medical Care Facilities | $5.2B | 97.0 | +4.0 | 93.8 | 46.3 | 97.0 | 81.8 | 80.3 | 85.7 | 83.3 | 48.5 | 22.0 | |
Vir Biotechnology, Inc. Biotechnology | $1.9B | 97.0 | +5.8 | 83.9 | 92.5 | 92.5 | 90.6 | 42.1 | 50.9 | 98.8 | 65.2 | 35.6 | |
Neurocrine Biosciences, Inc. Drug Manufacturers - Specialty & Generic | $15.9B | 96.7 | +8.7 | 84.5 | 99.1 | 64.5 | 97.0 | 43.8 | 75.6 | 91.2 | 99.5 | 11.1 | |
LivaNova Plc Medical Devices | $5.0B | 96.6 | −0.8 | 79.5 | 90.8 | 96.8 | 87.9 | 35.8 | 85.1 | 82.5 | 74.8 | 22.5 | |
Vericel Corp. Biotechnology | $2.6B | 96.5 | +2.8 | 84.9 | 60.6 | 85.3 | 96.4 | 62.6 | 74.0 | 79.1 | 82.4 | 31.1 | |
Regeneron Pharmaceuticals, Inc. Biotechnology | $94.9B | 96.3 | +2.4 | 96.3 | 95.1 | 89.7 | 82.9 | 37.2 | 77.3 | 78.7 | 96.4 | 2.7 | |
Neogen Corp. Medical Devices | $2.5B | 96.3 | +0.8 | 79.2 | 83.4 | 96.6 | 56.9 | 79.7 | 76.1 | 84.0 | 58.1 | 31.6 | |
Oscar Health, Inc. Healthcare Plans | $9.9B | 96.1 | +8.1 | 93.4 | 95.1 | 86.0 | 69.7 | 75.1 | 60.0 | 97.5 | 32.2 | 14.9 | |
West Pharmaceutical Services, Inc. Medical Instruments & Supplies | $28.2B | 96.1 | −0.1 | 98.7 | 79.4 | 94.9 | 83.9 | 41.0 | 75.2 | 76.0 | 96.1 | 7.6 | |
Jazz Pharmaceuticals Plc Biotechnology | $14.3B | 95.9 | +0.1 | 64.6 | 99.5 | 93.5 | 82.9 | 89.9 | 34.1 | 94.0 | 99.8 | 12.1 | |
Amgen, Inc. Drug Manufacturers - General | $248.1B | 95.9 | +1.5 | 81.9 | 91.9 | 95.7 | 97.1 | 49.9 | 76.7 | 68.8 | 97.9 | 1.0 | |
Revvity, Inc. Diagnostics & Research | $16.8B | 95.8 | +0.2 | 84.1 | 87.8 | 93.0 | 57.9 | 73.8 | 98.1 | 64.9 | 78.9 | 10.8 |
Today’s snapshot only — the list rotates as the scores move. Click any ticker for its full page: rank against every factor, analyst price targets, financials and news.
What these healthcare stocks look like up close.
Figures for the 25 listed names, from the same data behind their stock pages.
20 of the 25 names with analyst coverage this month carry a Buy-or-better majority.
Cheapest on trailing P/E: AUPH at 7.1×, MD at 16.8× and REGN at 20.0×.
Highest forward dividend yields: AMGN at 2.2%, RPRX at 1.4% and CAH at 0.8%.
Where we've written the stock up.
An analyst-style read on the business behind the score — published on the stock page.
This page is one list. Monday covers the whole market.
The names above rotate as the scores move. The Radar is how you hear what changed.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Questions people ask about healthcare stocks.
- What are the best healthcare stocks right now?
- As at 5 Nov 2026, the top-ranked healthcare stocks on Ticker Nerd's systematic factor model are Exelixis, Inc. (EXEL), Xeris Biopharma Holdings, Inc. (XERS), Progyny, Inc. (PGNY). The full top 25 is the table on this page, re-ranked every trading day. A rank is general information, not personal advice.
- How does Ticker Nerd pick the best healthcare stocks?
- Nobody picks them. A factor model scores roughly 4,600 US stocks every trading day on families like value, momentum, quality and growth, and this page is one fixed cut of that ranking. The research process behind the model — point-in-time data from 2005, locked test windows, logged rejections — is published on the methodology page.
- Are healthcare stocks a good investment?
- That depends on the price paid and on your circumstances — this page is general information, not advice. What the data says as at 5 Nov 2026: of the 25 listed names with analyst coverage this month, 20 carry a Buy-or-better majority, and every rank above is a percentile across roughly 4,600 US stocks.
The same model, other cuts.
Every list reads the one ranking — the stock screener index has the complete set.